JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.4
Cite Score
SJR: 0.114 / SNIP: 0.090
Volume 16, Issue 2 (2024)
Iran J War Public Health 2024, 16(2): 201-205 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2024/06/28 | Accepted: 2024/08/15 | Published: 2024/08/30
Received: 2024/06/28 | Accepted: 2024/08/15 | Published: 2024/08/30
How to cite this article
Al-Oudah G, Ali S, Mohammed S, Al-Ameedee H, Al-Ameedee A, Sahib A et al . Clinical and Anti-Oxidant Effect of Adding CoQ10 to Biological Therapy in Treating Moderate to Severe Psoriasis. Iran J War Public Health 2024; 16 (2) :201-205
URL: http://ijwph.ir/article-1-1504-en.html
URL: http://ijwph.ir/article-1-1504-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Authors
G.A. Al-Oudah *1, S.A.J. Ali2, S.M. Mohammed3, H.A. Al-Ameedee4, A.A. Al-Ameedee4, A.S. Sahib5, M.K. Al-Hattab6
1- Pharmacy College, Al-Mustaqbal University, Babylon, Iraq
2- Al-Safwa University College, Karbala, Iraq
3- Pharmacy College, Al-Mustaqbal University, Babil, Iraq
4- Babil Health Directorate, Iraqi Ministry of Health, Babil, Iraq
5- Department of Pharmacology, College of Pharmacy, University of Karbala, Karbala, Iraq
6- Department of Dermatology, Hammurabi Medical College, University of Babylon, Babylon, Iraq
2- Al-Safwa University College, Karbala, Iraq
3- Pharmacy College, Al-Mustaqbal University, Babil, Iraq
4- Babil Health Directorate, Iraqi Ministry of Health, Babil, Iraq
5- Department of Pharmacology, College of Pharmacy, University of Karbala, Karbala, Iraq
6- Department of Dermatology, Hammurabi Medical College, University of Babylon, Babylon, Iraq
Abstract (246 Views)
Aims: Psoriasis is a complex, chronic, immune-mediated, and hereditary skin disease. The present study attempted to determine whether adding CoQ10 to biological therapy can help relieve inflammation in Iraqi patients suffering from moderate to severe psoriasis.
Materials & Methods: A prospective, double-blind clinical trial took place in the Department of Dermatology at Merjan Teaching Hospital in Babylon, Iraq, over three months from August to November 2021. 30 individuals from 17 to 72 years old with persistent plaque psoriasis who met the criteria for biological therapy were selected by the available sampling method. Participants were allocated into two groups (each 15 members); Group A was treated with Adalimumab + placebo (corn starch), and Group B was treated with Adalimumab + 100mg CoQ10 adjuvant. The Psoriasis Area and Severity Index (PASI) score was utilized. The sera were utilized to calculate the human superoxide dismutase and malondialdehyde via the ELISA technique.
Findings: When compared to the patients before treatment, the two groups showed a substantial decline (p<0.05) after treatment; However, group B, which added CoQ10 to biological treatment, showed a highly significant decrease (p<0.05) in mean SOD level and MDA after treatment. Furthermore, following twelve weeks of treatment, group B's use of combined adjuvant therapy showed even greater recovery, as indicated by a 79% PIC PASI score improvement instead of a 60% PIC score.
Conclusion: Daily administration of 100mg CoQ10 supplements to psoriatic subjects for 12 weeks has beneficial effects on reducing oxidative stress.
Materials & Methods: A prospective, double-blind clinical trial took place in the Department of Dermatology at Merjan Teaching Hospital in Babylon, Iraq, over three months from August to November 2021. 30 individuals from 17 to 72 years old with persistent plaque psoriasis who met the criteria for biological therapy were selected by the available sampling method. Participants were allocated into two groups (each 15 members); Group A was treated with Adalimumab + placebo (corn starch), and Group B was treated with Adalimumab + 100mg CoQ10 adjuvant. The Psoriasis Area and Severity Index (PASI) score was utilized. The sera were utilized to calculate the human superoxide dismutase and malondialdehyde via the ELISA technique.
Findings: When compared to the patients before treatment, the two groups showed a substantial decline (p<0.05) after treatment; However, group B, which added CoQ10 to biological treatment, showed a highly significant decrease (p<0.05) in mean SOD level and MDA after treatment. Furthermore, following twelve weeks of treatment, group B's use of combined adjuvant therapy showed even greater recovery, as indicated by a 79% PIC PASI score improvement instead of a 60% PIC score.
Conclusion: Daily administration of 100mg CoQ10 supplements to psoriatic subjects for 12 weeks has beneficial effects on reducing oxidative stress.
Keywords:
References
1. Khmaladze I, Kelkka T, Guerard S, Wing K, Pizzolla A, Saxena A, et al. Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice. Proc Natl Acad Sci U S A. 2014;111(35):E3669-78. [Link] [DOI:10.1073/pnas.1405798111]
2. Li S, Yan T, Yang JQ, Oberley TD, Oberley LW. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res. 2000;60(14):3927-39. [Link]
3. Sourris KC, Harcourt BE, Tang PH, Morley AL, Huynh K, Penfold SA, et al. Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes. Free Radic Biol Med. 2012;52(3):716-23. [Link] [DOI:10.1016/j.freeradbiomed.2011.11.017]
4. Kaur M, Sharma S, Kukreja S, Kaur J, Bassi R. Study of oxidative stress in patients of psoriasis. Int J Res Dermatol. 2016;2(4):95-8. [Link] [DOI:10.18203/issn.2455-4529.IntJResDermatol20164007]
5. Briganti S, Picardo M. Antioxidant activity, lipid peroxidation and skin diseases. What's new. J Eur Acad Dermatol Venereol. 2003;17(6):663-9. [Link] [DOI:10.1046/j.1468-3083.2003.00751.x]
6. Pleńkowska J, Gabig-Cimińska M, Mozolewski P. Oxidative stress as an important contributor to the pathogenesis of psoriasis. Int J Mol Sci. 2020;21(17):6206. [Link] [DOI:10.3390/ijms21176206]
7. Kanda N. Psoriasis: Pathogenesis, comorbidities, and therapy updated. Int J Mol Sci. 2021;22(6):2979. [Link] [DOI:10.3390/ijms22062979]
8. Reczek CR, Chandel NS. ROS-dependent signal transduction. Curr Opin Cell Biol. 2015;33:8-13. [Link] [DOI:10.1016/j.ceb.2014.09.010]
9. Kadam DP, Suryakar AN, Ankush RD, Kadam CY, Deshpande KH. Role of oxidative stress in various stages of psoriasis. Indian J Clin Biochem. 2010;25(4):388-92. [Link] [DOI:10.1007/s12291-010-0043-9]
10. Hashemi M, Mehrabifar H, Daliri M, Ghavami S. Adenosine deaminase activity, trypsin inhibitory capacity and total antioxidant capacity in psoriasis. J Eur Acad Dermatol Venereol. 2010;24(3):329-34. [Link] [DOI:10.1111/j.1468-3083.2009.03416.x]
11. Sikar Aktürk A, Özdoğan HK, Bayramgürler D, Çekmen MB, Bilen N, Kıran R. Nitric oxide and malondialdehyde levels in plasma and tissue of psoriasis patients. J Eur Acad Dermatol Venereol. 2012;26(7):833-7. [Link] [DOI:10.1111/j.1468-3083.2011.04164.x]
12. Han Y, Huang C, Sun X, Xiang B, Wang M, Yeh ET, et al. SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress. J Biol Chem. 2010;285(17):12906-15. [Link] [DOI:10.1074/jbc.M109.071431]
13. Sifuentes-Franco S, Sánchez-Macías DC, Carrillo-Ibarra S, Rivera-Valdés JJ, Zuñiga LY, Sánchez-López VA. Antioxidant and anti-inflammatory effects of coenzyme Q10 supplementation on infectious diseases. Healthcare. 2022;10(3):487. [Link] [DOI:10.3390/healthcare10030487]
14. Mantle D, Dybring A. Bioavailability of coenzyme Q10: An overview of the absorption process and subsequent metabolism. Antioxidants. 2020;9(5):386. [Link] [DOI:10.3390/antiox9050386]
15. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417(1):1-13. [Link] [DOI:10.1042/BJ20081386]
16. Lenaz G, Fato R, Formiggini G, Genova ML. The role of Coenzyme Q in mitochondrial electron transport. Mitochondrion. 2007;7:S8-33. [Link] [DOI:10.1016/j.mito.2007.03.009]
17. Tsai HY, Lin CP, Huang PH, Li SY, Chen JS, Lin FY, et al. Coenzyme Q10 attenuates high glucose-induced endothelial progenitor cell dysfunction through AMP-activated protein kinase pathways. J Diabetes Res. 2016;2016:6384759. [Link] [DOI:10.1155/2016/6384759]
18. Turunen M, Olsson J, Dallner G. Metabolism and function of coenzyme Q. Biochimica Biophysica Acta (BBA)-Biomembranes. 2004;1660(1-2):171-99. [Link] [DOI:10.1016/j.bbamem.2003.11.012]
19. Mantle D. Coenzyme Q10 supplementation for diabetes and its complications: An overview. 2017;17(4). [Link] [DOI:10.15277/bjd.2017.149]
20. Abdollahzad H, Aghdashi MA, Asghari Jafarabadi M, Alipour B. Effects of Coenzyme Q10 supplementation on inflammatory cytokines (TNF-α, IL-6) and oxidative stress in rheumatoid arthritis patients: A randomized controlled trial. Arch Med Res. 2015;46(7):527-33. [Link] [DOI:10.1016/j.arcmed.2015.08.006]
21. Samimi F, Baazm M, Eftekhar E, Rajabi S, Goodarzi MT, Mashayekhi FJ. Possible antioxidant mechanism of Coenzyme Q10 in diabetes: Impact on Sirt1/Nrf2 signaling pathways. Res Pharm Sci. 2019;14(6):524-33. [Link] [DOI:10.4103/1735-5362.272561]
22. Zhai J, Bo Y, Lu Y, Liu C, Zhang L. Effects of Coenzyme Q10 on markers of inflammation: A systematic review and meta-analysis. PloS One. 2017;12(1):e0170172. [Link] [DOI:10.1371/journal.pone.0170172]
23. Dludla PV, Orlando P, Silvestri S, Marcheggiani F, Cirilli I, Nyambuya TM, et al. Coenzyme Q10 supplementation improves adipokine levels and alleviates inflammation and lipid peroxidation in conditions of metabolic syndrome: A meta-analysis of randomized controlled trials. Int J Mol Sci. 2020;21(9):3247. [Link] [DOI:10.3390/ijms21093247]
24. Cirilli I, Damiani E, Dludla PV, Hargreaves I, Marcheggiani F, Millichap LE, et al. Role of Coenzyme Q10 in health and disease: An update on the last 10 years (2010-2020). Antioxidants. 2021;10(8):1325. [Link] [DOI:10.3390/antiox10081325]
25. Zozina VI, Covantev S, Goroshko OA, Krasnykh LM, Kukes VG. Coenzyme Q10 in cardiovascular and metabolic diseases: Current state of the problem. Curr Cardiol Rev. 2018;14(3):164-74. [Link] [DOI:10.2174/1573403X14666180416115428]
26. Abdel-Mawla MY, Nofal E, Khalifa N, Abdel-Shakoor R, Nasr M. Role of oxidative stress in psoriasis: An evaluation study. J Am Sci. 2013;9(8):151-5. [Link]
27. Lisse TS, King BL, Rieger S. Comparative transcriptomic profiling of hydrogen peroxide signaling networks in zebrafish and human keratinocytes: Implications toward conservation, migration and wound healing. Sci Rep. 2016;6:20328. [Link] [DOI:10.1038/srep20328]
28. Barygina V, Becatti M, Prignano F, Lotti T, Taddei N, Fiorillo C. Fibroblasts to keratinocytes redox signaling: The possible role of ROS in psoriatic plaque formation. Antioxidants. 2019;8(11):566. [Link] [DOI:10.3390/antiox8110566]
29. Lord CJ, Ashworth A. The DNA damage response and cancer therapy. Nature. 2012;481:287-94. [Link] [DOI:10.1038/nature10760]
30. Pujari VM, Ireddy S, Itagi I, Kumar HS. The serum levels of malondialdehyde, vitamin e and erythrocyte catalase activity in psoriasis patients. J Clin Diagn Res. 2014;8(11):CC14-6. [Link] [DOI:10.7860/JCDR/2014/10912.5085]
31. Relhan V, Gupta SK, Dayal S, Pandey R, Lal H. Blood thiols and malondialdehyde levels in psoriasis. J Dermatol. 2002;29(7):399-403. [Link] [DOI:10.1111/j.1346-8138.2002.tb00293.x]
32. Sunitha S, Rajappa M, Thappa D, Chandrashekar L, Munisamy M, Revathy G, et al. Comprehensive lipid tetrad index, atherogenic index and lipid peroxidation: Surrogate markers for increased cardiovascular risk in psoriasis. Indian J Dermatol Venereol Leprol. 2015;81(5):464-71. [Link] [DOI:10.4103/0378-6323.163734]
33. Corrocher R, Ferrari S, De Gironcoli M, Bassi A, Olivieri O, Guarini P, et al. Effect of fish oil supplementation on erythrocyte lipid pattern, malondialdehyde production and glutathione-peroxidase activity in psoriasis. Clin Chim Acta. 1989;179(2):121-31. [Link] [DOI:10.1016/0009-8981(89)90158-7]
34. Florence TM. The role of free radicals in disease. Aust N Z J Ophthalmol. 1995;23(1):3-7. [Link] [DOI:10.1111/j.1442-9071.1995.tb01638.x]
35. De Haan JB, Cristiano F, Iannello RC, Kola I. Cu/Zn-superoxide dismutase and glutathione peroxidase during aging. Biochem Mol Biol Int. 1995;35(6):1281-97. [Link]
36. Thérond P, Gerbaud P, Dimon S, Anderson WB, Evain-Brion D, Raynaud F. Antioxidant enzymes in psoriatic fibroblasts and erythrocytes. J Invest Dermatol. 1996;106(6):1325-31. [Link] [DOI:10.1111/1523-1747.ep12349055]
37. Skutnik-Radziszewska A, Maciejczyk M, Fejfer K, Krahel J, Flisiak I, Kołodziej U, et al. Salivary antioxidants and oxidative stress in psoriatic patients: Can salivary total oxidant status and oxidative status index be a plaque psoriasis biomarker?. Oxid Med Cell Longev. 2020;2020:9086024. [Link] [DOI:10.1155/2020/9086024]
38. Lai R, Xian D, Xiong X, Yang L, Song J, Zhong J. Proanthocyanidins: Novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and Treg cells. Redox Rep. 2018;23(1):130-5. [Link] [DOI:10.1080/13510002.2018.1462027]
39. Kyriakis JM, Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: A 10-year update. Physiol Rev. 2012;92(2):689-737. [Link] [DOI:10.1152/physrev.00028.2011]
40. Schmidt KN, Amstad P, Cerutti P, Baeuerle PA. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB. Chem Biol. 1995;2(1):13-22. [Link] [DOI:10.1016/1074-5521(95)90076-4]
41. Johansen C, Kragballe K, Westergaard M, Henningsen J, Kristiansen K, Iversen L. The mitogen‐activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br J Dermatol. 2005;152(1):37-42. [Link] [DOI:10.1111/j.1365-2133.2004.06304.x]
42. Yu XJ, Li CY, Dai HY, Cai DX, Wang KY, Xu YH, et al. Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin. Exp Mol Pathol. 2007;83(3):413-8. [Link] [DOI:10.1016/j.yexmp.2007.05.002]
43. Medovic MV, Jakovljevic VL, Zivkovic VI, Jeremic NS, Jeremic JN, Bolevich SB, et al. Psoriasis between autoimmunity and oxidative stress: Changes induced by different therapeutic approaches. Oxid Med Cell Longev. 2022;2022:2249834. [Link] [DOI:10.1155/2022/2249834]
44. Barygina VV, Becatti M, Soldi G, Prignano F, Lotti T, Nassi P, et al. Altered redox status in the blood of psoriatic patients: Involvement of NADPH oxidase and role of anti-TNF-α therapy. Redox Rep. 2013;18(3):100-6. [Link] [DOI:10.1179/1351000213Y.0000000045]
45. Bacchetti T, Campanati A, Ferretti G, Simonetti O, Liberati G, Offidani AM. Oxidative stress and psoriasis: The effect of antitumour necrosis factor‐α inhibitor treatment. Br J Dermatol. 2013;168(5):984-9. [Link] [DOI:10.1111/bjd.12144]
46. Pastore S, Mariani V, Lulli D, Gubinelli E, Raskovic D, Mariani S, et al. Glutathione peroxidase activity in the blood cells of psoriatic patients correlates with their responsiveness to Efalizumab. Free Radic Res. 2011;45(5):585-99. [Link] [DOI:10.3109/10715762.2011.560150]
47. Beyazit F, Büyük B, Turkon H, Elmas S, Uzun M. Adalimumab mitigates ovarian ischemia-reperfusion injury in rats by regulating oxidative stress, apoptosis and resolution of inflammation. J Obstet Gynaecol Res. 2019;45(2):358-67. [Link] [DOI:10.1111/jog.13846]
48. Börcek AÖ, Çivi S, Öcal Ö, Gülbahar Ö. Effects of tumor necrosis factor alpha blocker adalimumab in experimental spinal cord injury. J Korean Neurosurg Soc. 2015;57(2):73-6. [Link] [DOI:10.3340/jkns.2015.57.2.73]
49. De La Cámara CMF, Hernández-Pinto AM, Olivares-González L, Cuevas-Martín C, Sánchez-Aragó M, Hervás D, et al. Adalimumab reduces photoreceptor cell death in a mouse model of retinal degeneration. Sci Rep. 2015;5:11764. [Link] [DOI:10.1038/srep11764]
50. Al-Oudah GA, Sahib AS, Al-Hattab MK, Al-Ameedee AA. Effect of CoQ10 administration to psoriatic Iraqi patients on biological therapy upon severity index (PASI) and quality of life index (DLQI) before and after therapy. J Popul Ther Clin Pharmacol. 2022;29(2):e52-60. [Link] [DOI:10.47750/jptcp.2022.931]